PlainPharmaWatch

CMS Open Payments · Program Year 2024

Perfuze Inc

Perfuze Inc reported $5,756.90 in payments to 5 physicians and teaching hospitals across 6 transactions.

See the rankings → How this is sourced
$5.8K
Total payments
6
Transactions
5
Recipients
#1699
of 1,925 companies

Perfuze Inc reported $5,756.90 in payments to 5 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1699 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.2K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Perfuze Inc pairs modest payment volume with a moderately concentrated payment pattern.

#1699
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
1
payment categories

How Perfuze Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Perfuze Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$5,757 12th percentile higher than 12% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). This entry sits in this band. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Perfuze Inc

Perfuze Inc ranks #1699 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $5,756.90 across 6 transactions to 5 physicians and teaching hospitals - $959.48 per transaction and $1.2K per recipient on average.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $756.90 across 5 transactions, 13.1% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 1 types of general payments, Perfuze Inc's largest category was "Food and Beverage" at $756.90 - 13.1% of the company's reported total.

How Perfuze Inc divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$756.90
Payment Type Amount Transactions
Food and Beverage $756.90 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $756.90 (100.0%) of $756.90 in this company's General Payments records across 5 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Perfuze Inc

The five named recipients with the highest reported General Payments from this company

Waldo Guerrero$194.66Haydn Hoffman$140.56Ehizele Osehobo$140.56Bhageeradh Mulpur$140.56Nicolas Khattar$140.56
  1. 1

    Waldo Guerrero

    $194.66 across 1 reported transactions

  2. 2

    Haydn Hoffman

    $140.56 across 1 reported transactions

  3. 3

    Ehizele Osehobo

    $140.56 across 1 reported transactions

  4. 4

    Bhageeradh Mulpur

    $140.56 across 1 reported transactions

  5. 5

    Nicolas Khattar

    $140.56 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $959.48. Average per recipient: $1.2K.

Total Amount

$5,756.90

Avg per Transaction

$959.48

Avg per Recipient

$1.2K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Perfuze Inc Share

0.0%

#1699 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Perfuze Inc

ReShape Lifesciences Inc.

$5.8K 15 recipients

Bridge to Life Ltd

$5.6K 9 recipients

Rare Disease Therapeutics, Inc.

$5.6K 104 recipients

DentalEZ Alabama, Inc.

$5.9K 13 recipients

Karl Storz Endovision, Inc.

$5.5K 3 recipients

Granata Bio Corporation

$5.5K 22 recipients

Frequently Asked Questions

How much did Perfuze Inc pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $5,756.90 from Perfuze Inc to physicians and hospitals across 6 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Perfuze Inc? ▾
Perfuze Inc made payments to 5 physicians and teaching hospitals in 2024. The average payment per recipient was $1.2K.
What types of payments did Perfuze Inc make? ▾
1 categories of general payment make up Perfuze Inc's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Food and Beverage" at $756.90, representing 13.1% of the company's reported total.
How does Perfuze Inc rank among pharmaceutical companies? ▾
By total payment amount, Perfuze Inc sits at #1699 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Perfuze Inc? ▾
The average transaction from Perfuze Inc was $959.48 in 2024. The company made 6 total transactions to 5 recipients.
Where does the payment data for Perfuze Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Perfuze Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.